Overview / Abstract: |
The rapid evolution of treatment advances in chronic lymphocytic leukemia (CLL) make treatment a complex and challenging proposition. Though several randomized, controlled trials on the use of novel targeted biologic agents in CLL have been conducted, there are limited published, randomized data providing definitive guidance on treatment selection (including drug combinations and sequencing therapy), duration of treatment, management of treatment-related toxicities, and disease outcomes across different lines of therapy. This activity has been developed to help clinicians involved in the management of patients with CLL effectively apply the newest available tailored treatments while considering such clinical features of CLL as The implications of serum, molecular, and cytogenetic biomarkers on patient prognosis |
Expiration |
Mar 30, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. |
Accreditation |
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and RedMedEd. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Presenters / Authors / Faculty |
Anthony Mato, MD, MSCE—Program Chair John M. Pagel, MD, PhD Chaitra S. Ujjani, MD |
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Internal Medicine, Hematology |
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from AbbVie; Pharmacyclics LLC, an AbbVie Company; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. |
Keywords / Search Terms |
Virtual, Interactive, CME, Free, RedMedEd, Patient case, MCL, CLL, Non Hodgkin lymphoma, B cell lymphoma, Mantle cell lymphoma, Chronic lymphocytic leukemia, Oncology, Hematology, BTK, Bruton tyrosine kinase, Diagnosis, Prognosis, Treatment options, Immunotherapy, Targeted therapy, Oncologist, Hematologist, Advances, Treatment, Cancer, Chemoimmunotherapy, Small lymphocytic lymphoma, Guidelines, Recommendations, Biologic |